☰
✕

Cancer Is West Africa's Silent Security Crisis

For most of West Africa, cancer is not only a medical emergency but a failure of systems. The region is used to thinking of threats in terms of insurgents and coups, yet a diagnosis here often carries a quieter sentence: late detection, unaffordable treatment, and death at home.

Nigeria shows the scale. The country records over 100,000 new cancer cases and 70,000 deaths a year, and the five-year breast cancer survival rate is 25.6 per cent, against over 80 per cent in developed nations. More than 70 per cent of breast cancer cases are diagnosed at an advanced stage. Poor data means the real picture is likely worse, because many patients die without ever reaching a hospital.

The deeper problem is capacity. Nigeria has only about ten functional radiotherapy machines, fewer than 70 clinical oncologists, and fewer than 200 pathologists. Over half of the oncology workforce is concentrated in Lagos, leaving the north and rural areas largely unserved. Neighbouring states face the same pattern: a few tertiary centres in capital cities, and long journeys for everyone else. Specialists keep leaving for better pay abroad.

Cost turns a treatable disease into a death sentence. Patients are abandoning orthodox treatment for herbal remedies, driven by financial desperation rather than choice. Families sell land, drain savings and crowdfund through WhatsApp groups. Stigma and misconceptions add delay, so patients arrive when little can be done.

Because no country in the region can fix this alone, I would argue for four steps:

Regional centres of excellence. Pool radiotherapy and pathology capacity through ECOWAS and the West African Health Organisation, so patients are not stranded between borders.

Insurance that covers cancer. National health schemes must include screening and treatment, not only consultations.

Early detection in communities. Train community health workers, use mobile screening, and take awareness into mosques, churches, markets and Zongo communities in local languages.

Keep the workforce. Better pay, training pipelines and bonded fellowships can slow the exodus of oncologists.

There are signs of movement. Nigeria has unveiled a National Cancer Control Plan for 2026–2030, prioritising prevention, early detection and sustainable financing. But plans only matter if they are funded and reach the north, the Sahel and the coast alike.

A region that can mobilise troops and summits across borders can mobilise for its sick. Cancer care is a question of dignity and stability, and our leaders should treat it as one.

Mustapha Bature Sallama
Medical/ Science Communicator,
Private Investigator, Criminal Investigation and Intelligence Analysis,

International Conflict Management and Peacebuilding. (USIP)

Mustysallama@gmail.com
+233555275880

References
Daily Trust, "Hospital bill worse than cancer – Patient," February 2026. https://dailytrust.com/hospital-bill-worse-than-cancer-patient (also on

AllAfrica: https://allafrica.com/stories/202602040383.html)

Supports: ten functional radiotherapy machines; fewer than 70 clinical oncologists and fewer than 200 pathologists; over half of the workforce in Lagos; more than 70 per cent of breast cancer cases diagnosed late; patients turning to herbal remedies.

Daily Trust editorial, "Cancer and the cost of survival," World Cancer Day 2026. https://dailytrust.com/?p=1865209

Supports: over 100,000 new cases and 70,000 deaths a year; 25.6 per cent five-year breast cancer survival versus over 80 per cent in developed nations; the National Cancer Control Plan (2026–2030).

Daily Trust, "World Cancer Day: Closing the gap in cancer care in Nigeria." https://dailytrust.com/?p=1183196

Useful for: the poor-data point from the Nigeria Cancer Society's president. It is an older piece, so check the date before citing.

Author has 2161 publications here on modernghana.com

Disclaimer: "The views expressed in this article are the author’s own and do not necessarily reflect ModernGhana official position. ModernGhana will not be responsible or liable for any inaccurate or incorrect statements in the contributions or columns here."

   Comments0

More From Author